Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Efficacy and Safety of Ginkgo Biloba Extract EGb761® in Patients With Diabetic Retinopathy: A Single-Center, Open-Label, Parallel-Group Controlled Trial

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07236645
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:57.389094+00:00
Published At
2025-11-19T00:00:00+00:00
Record Updated At
2025-11-19
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Non-proliferative Diabetic Retinopathy (NPDR)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-11-19"
protocolSection.identificationModule.nctId
"NCT07236645"
protocolSection.identificationModule.officialTitle
"Efficacy and Safety of Ginkgo Biloba Extract EGb761\u00ae in Patients With Diabetic Retinopathy: A Single-Center, Open-Label, Parallel-Group Controlled Trial"
protocolSection.statusModule.overallStatus
"NOT_YET_RECRUITING"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Non-proliferative Diabetic Retinopathy (NPDR) (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.